EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study (EnSite RT CPM)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00632450|
Recruitment Status : Completed
First Posted : March 10, 2008
Last Update Posted : March 29, 2010
The EnSite Real-Time Cardiac Performance Measurements Study (EnSite RT CPM) is a multicenter, international, acute, non-significant risk study, designed to enroll a maximum of 40 patient. The goal of the study is to collect 3-D systolic/diastolic data with the EnSite NavX Mapping system during a CRT implant.
Patients enrolled in this study will undergo NavX CPM recording of the heart using the EnSite NavX Mapping system during the implantation of a cardiac resynchronization therapy device.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||21 participants|
|Official Title:||EnSite Real-Time Cardiac Performance Measurements Study, a Non-significant Risk Study|
|Study Start Date :||December 2007|
|Actual Primary Completion Date :||October 2008|
|Actual Study Completion Date :||October 2008|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00632450
|United States, California|
|St. Jude Medical|
|Sunnyvale, California, United States, 94086|
|Principal Investigator:||Johannes Sperzel, MD||Kerckhoff Klinik GmbH|
|Principal Investigator:||Andre d'Avila, MD||Massachusetts General Hospital|
|Principal Investigator:||Imran Niazi, MD||Arrhythmia Center of Southern Wisconsin, Ltd|